FEV
Protein FEV
Also known as: FEV_HUMAN, Pet-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99581
- Gene
- FEV
- Ensembl
- ENSG00000163497
- Chromosome
- 2
- Canonical length
- 238 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
This gene belongs to the ETS transcription factor family. ETS family members have a highly conserved 85-amino acid ETS domain that binds purine-rich DNA sequences. The alanine-rich C-terminus of this gene indicates that it may act as a transcription repressor. This gene is exclusively expressed in neurons of the central serotonin (5-HT) system, a system implicated in the pathogeny of such psychiatric diseases as depression, anxiety, and eating disorders. In some types of Ewing tumors, this gene is fused to the Ewing sarcoma (EWS) gene following chromosome translocations. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
238 residues, UniProt reviewed canonical sequence.
>Q99581|FEV
1 MRQSGASQPL LINMYLPDPV GDGLFKDGKN PSWGPLSPAV QKGSGQIQLW QFLLELLADR
61 ANAGCIAWEG GHGEFKLTDP DEVARRWGER KSKPNMNYDK LSRALRYYYD KNIMSKVHGK
121 RYAYRFDFQG LAQACQPPPA HAHAAAAAAA AAAAAQDGAL YKLPAGLAPL PFPGLSKLNL
181 MAASAGVAPA GFSYWPGPGP AATAAAATAA LYPSPSLQPP PGPFGAVAAA SHLGGHYHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FEV can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 4 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 4 nTPM
- pituitary gland: 3.3 nTPM
- prostate: 3 nTPM
- stomach: 3 nTPM
- adrenal gland: 2.2 nTPM
- small intestine: 2 nTPM
Single-cell type
- neuroendocrine cells: 566 nCPM
- pancreatic islet cells: 71 nCPM
- prostatic glandular cells: 4 nCPM
- paneth cells: 3.9 nCPM
- lactotrophs: 2.4 nCPM
- enteric transient amplifying cells: 1.9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 154 nTPM
- pons: 43 nTPM
- medulla oblongata: 13 nTPM
- basal ganglia: 3.6 nTPM
- cerebral cortex: 1.4 nTPM
- hippocampal formation: 1.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FEV.
Disease | AllUniProt
Conditions FEV is implicated in, by any mechanism.
- Sudden infant death syndrome (SIDS) MIM:272120
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.32
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.43
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- maternal behavior
- neuron fate specification
- neuron maturation
- positive regulation of gene expression
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FEV as an antibody target. Whether an autoantibody or antibody against FEV could matter depends on whether native FEV is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FEV is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FEV as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...